The rediscovery and isolation of TFPI

Journal of Thrombosis and Haemostasis

Volumn 1, Issue 8, 2003, Pages 1671-1675

  Broze Jr , G J ^a  

^a BARNES JEWISH HOSPITAL   (United States)

Author keywords

Factor VII; TFPI; Tissue factor

Indexed keywords

BLOOD CLOTTING FACTOR 7; LIPOPROTEIN; LIPOPROTEIN-ASSOCIATED COAGULATION INHIBITOR; THROMBOPLASTIN; TISSUE FACTOR PATHWAY INHIBITOR;

ANIMAL; ARTICLE; BIOCHEMISTRY; BIOLOGICAL MODEL; CHEMISTRY; HISTORY; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; RABBIT; UNITED STATES;

ANIMALS; BIOCHEMISTRY; FACTOR VII; HISTORY, 20TH CENTURY; HUMANS; LIPOPROTEINS; MODELS, BIOLOGICAL; RABBITS; THROMBOPLASTIN; UNITED STATES;

EID: 2142761470     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1046/j.1538-7836.2003.00391.x     Document Type: Note

References (55)

1. Sanders NL, Bajaj SP, Zivelin A, Rapaport SI. Inhibition of tissue factor/factor Vila activity in plasma requires factor X and an additional plasma component. Blood 1985; 66: 204-12. A preliminary report of these results was presented at the American Heart Association meeting in Anaheim, November 1983. Circulation 1983; 68 (Suppl. Ill): 317.
2. Loeb L. Weitere Untersuchungen uber Blutgerinnung. Beitr Chem Physiol Path 1904; 5: 534-57.
3. Dold H. Weitere Untersuchungen uber die wasserrigen Organextraktgifte und die entgiftende Wirkung frischen Serums. Dtsch Med Wochenschr 1911; II: 1644-7.
4. Loeb L, Fleisher MS, Tuttle L. The interaction between blood serum and tissue extract in the coagulation of blood. I. The combined action of serum and tissue extract on fluoride, hirudin, and peptone plasma; the effect of heating on the serum. J Biol Chem 1922; 51: 461-83.
5. Loeb L, Fleisher MS, Tuttle L. The interaction between blood serum and tissue extract in the coagulation of blood: II. A comparison between the effects of the stroma of erythrocytes and of tissue extracts, unheated and heated, on the coagulation of the blood, and on the mechanism of the interaction of these substances with blood serum. J Biol Chem 1922; 51: 485-506.
6. Thomas L. Studies on the intravascular thromboplastin effect of tissue suspensions in mice: II. A factor in normal rabbit serum which inhibits the thromboplastin effect of the sedimentable tissue component. Bull Johns Hopkins Hosp 1947; 81: 26-42.
7. Schneider CL. The active principle of placental toxin: thromboplastin; its inactivator in blood: anti-thromboplastin. Am J Physiol 1947; 149: 123-9.
8. Mann FD, Hum M. Inactivation of thromboplastin by serum. Fed Proc 1949; 8: 105 (Abstract).
9. McClaughry RI. The specificity of anti-thromboplastin activity. J Mich Med Soc 1950; 49: 685 (Abstract).
10. Tocantins LM. Demonstration of anti-thromboplastic activity in normal and hemophilic plasmas. Am J Physiol 1943; 139: 265-79.
11. Fiala S, Roth K. Platelets and the thromboplastic system of blood coagulation. Arch Int Physiol 1953; 61: 205-31.
12. Lanchantin GF, Ware AG. Identification of a thromboplastin inhibitor in serum and in plasma. J Clin Invest 1953; 32: 381-9.
13. Berry CG. The degeneration of brain thromboplastin in the presence of normal serum. J Clin Pathol 1957; 10: 342-5.
14. Deutsch E, Fuchs H. Naturlich vorkommende Koagulationsinhibitoren. Acta Haemat 1958; 20: 97-114.
15. Hjort PF. Intermediate reactions in the coagulation of blood with tissue thromoplastin. Chapter VI: Anti-convertin. Scand J Clin Lab Invest 1957; 9 (Suppl.): 76-97.
16. Rapaport SI, Aas K, Owren PA. The lipid inhibitor of brain: mechanism of its anticoagulant action and its comparison with the soybean inositol phosphatide inhibitor. J Lab Clin Med 1954; 44: 364-73.
17. Hermansky F, Vitek J. The role of proconvertin and Stuart factor in the inactivation of tissue thromboplastin by serum. Experientia 1960; 16: 455-6.
18. Manteuffel ZV. Bemerkungen zur Blustillung bein Haemophilie. Dtsch Med Wochenschr 1883; 19: 665-7.
19. Minot GR, Lee RI. The blood platelets in haemophilia. Arch Intern Med 1916; 18: 474-95.
20. MacFarlane RG. An enzyme cascade in the blood clotting mechanism, and its function as a biochemical amplifier. Nature 1964; 202: 498-9.
21. Davie EW, Ratnoff OD. Waterfall sequence for intrinsic blood clotting. Science 1964; 145: 1310-2.
22. Biggs R, MacFarlane RG. The reaction of haemophiliac plasma to thromboplastin. J Clin Invest 1951; 4: 445-59.
23. Biggs R, Nossel HL. Tissue extract and the contact reaction in blood coagulation. Thromb Diath Haemorrh 1961; 6: 1-14.
24. Josso F, Prou-Wartelle O. Interaction of tissue factor and factor VII at the earliest phase of coagulation. Thromb Diathesis Haemorrh 1965; 17 (Suppl.): 35-44.
25. Osterud B, Rapaport SI. Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation. Proc Natl Acad Sci USA 1977; 74: 5260-4.
26. Broze GJ Jr, Girard TJ, Novotny WE Regulation of coagulation by a multivalent Kunitz-type inhibitor. Biochemistry 1990; 29: 7539-46.
27. Lawson JH, Kalafatis M, Stram S, Mann KG. A model for the tissue factor pathway to thrombin. J Biol Chem 1994; 269: 23357-66.
28. Carson SD. Plasma high density lipoproteins inhibit the activation of coagulation factor X by factor Vila and tissue factor. FEBS Lett 1981; 132: 37-40.
29. Kondo S, Kisiel W. Evidence that plasma lipoproteins inhibit the factor Vila-tissue factor complex by a different mechanism than extrinsic pathway inhibitor. Blood 1987; 70: 1947-54.
30. Dahl PE, Abildgaard U, Larsen ML, Tjensvoll L. Inhibition of activated coagulation factor VII by normal human plasma. Thromb Haemost 1982; 48: 253-6.
31. Marlar RA, Kleiss AJ, Griffin JH. An alternative extrinsic pathway of human blood coagulation. Blood 1982; 60: 1353-8.
32. Morrison SA, Jesty J. Tissue factor-dependent activation of tritium-labeled factor lX and factor X in human plasma. Blood 1984; 63: 1338-47.
33. 125I-factor X: effect of tissue factor and factor VII, factor Xa and thrombin. Scand J Haematol 1980; 24: 213-26.
34. Broze GJ Jr, Majerus PW. Purification and properties of human coa-gulation factor VII. J Biol Chem 1980; 255: 1242-7.
35. Bajaj SP, Rapaport SI, Brown SF. Isolation and characterization of human factor VII. Activation of factor VII by factor Xa. J Biol Chem 1981; 256: 253-9.
36. Prowse CV, Esnouf MP. Isolation of a new warfarin-sensitive protein from bovine plasma. Biochem Soc Trans 1977; 5: 255-6.
37. Broze GJ Jr, Miletich JP. Human protein Z. J Clin Invest 1984; 73: 933-8.
38. Bach R, Nemerson Y, Konigsberg W. Purification and characterization of bovine tissue factor. J Biol Chem 1981; 256: 8324-31.
39. Bjorklid E, Storm E, Prydz H. The protein component of human brain thromboplastin. Biochem Biophys Res Commun 1973; 55: 969-76.
40. Bjorklid E, Holm T, Osterud B. The development of monospecific antibodies against human thromboplastin apoprotein (apoprotein III) and their application in the immunocytochemical detection of the antigen in blood cells. Thromb Res 1987; 45: 609-24.
41. Broze GJ Jr, Leykam JE, Schwartz BD, Miletich JP. Purification of human brain tissue factor. J Biol Chem 1985; 260: 10917-20.
42. Hubbard AR, Jennings CA. Inhibition of tissue thromboplastin-mediated blood coagulation. Thromb Res 1986; 42: 489-98.
43. Hubbard AR, Jennings CA. Inhibition of the tissue factor-factor VII complex: involvement of factor Xa and lipoproteins. Thromb Res 1987; 46: 527-37.
44. Rao LV, Rapaport SI. Studies of a mechanism inhibiting the initiation of the extrinsic pathway of coagulation. Blood 1987; 69: 645-51.
45. Broze GJ Jr, Miletich JP. Characterization of the inhibition of tissue factor in serum. Blood 1987; 69: 150-5.
46. Sandset PM, Abildgaard U, Pettersen M. A sensitive assay of extrinsic coagulation pathway inhibitor (EPI) in plasma and plasma fractions. Thromb Res 1987; 47: 389-400.
47. Sandset PM, Abildgaard U, Larsen ML. Heparin induces release of extrinsic coagulation pathway inhibitor (EPI). Thromb Res 1988; 50: 803-13.
48. Coburn P, Buonassisi V. Identification of an endothelial cell product as an inhibitor of tissue factor activity. In Vitro CellDev Biol 1988; 24: 1133-6.
49. Warn-Cramer BJ, Maki SL, Rapaport SI. A sulfated rabbit endothelial cell glycoprotein that inhibits factor Vila/tissue factor is functionally and immunologically identical to rabbit extrinsic pathway inhibitor (EPI). Thromb Res 1991; 61: 515-27.
50. Broze GJ Jr, Miletich JP. Isolation of the tissue factor inhibitor produced by HepG2 hepatoma cells. Proc Natl Acad Sci USA 1987; 84: 1886-90.
51. Broze GJ Jr, Warren LA, Novotny WF, Higuchi DA, Girard JJ, Miletich JP. The lipoprotein-associated coagulation inhibitor that inhibits the factor VH-tissue factor complex also inhibits factor Xa: insight into its possible mechanism of action. Blood 1988; 71: 335-043.
52. Broze GJ Jr, Warren LA, Girard JJ, Miletich JP. Isolation of the lipo-protein-associated coagulation inhibitor produced by HepG2 cells using bovine factor Xa affinity chromatography. Thromb Res 1987; 48: 253-9.
53. Wun T-C, Kretzmer KK, Girard TJ, Miletich JP, Broze GJ Jr. Cloning and characterization of a cDNA coding for the lipoprotein-associated coagulation inhibitor shows that it consists of three tandem Kunitz-type inhibitory domains. J Biol Chem 1988; 263: 6001-4.
54. Warn-Cramer BJ, Maki SL, Zivelin A, Rapaport SI. Partial purification and characterization of the extrinsic pathway inhibitor. Thromb Res 1987; 48: 11-22.
55. Baugh RJ, Broze GJ Jr, Krishnaswamy S. Regulation of extrinsic pathway factor Xa formation by tissue factor pathway inhibitor. J Biol Chem 1998; 273: 4378-86.